We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+12.74%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,452.87%
AUM
$1.08B
AUM Growth
+$88.6M
Cap. Flow
-$9.3M
Cap. Flow %
-0.86%
Top 10 Hldgs %
22.54%
Holding
246
New
35
Increased
107
Reduced
81
Closed
17

Sector Composition

Rank Sector Weight
1 Technology 32.98%
2 Healthcare 18.74%
3 Industrials 9.67%
4 Financials 8.9%
5 Consumer Discretionary 8.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDFS icon
26
PDF Solutions
PDFS
$2.07B
$11.2M 1.03%
681,698
+320,818
+89% +$5.95M
IVC
27
DELISTED
Invacare Corporation
IVC
$10.7M 0.99%
813,730
+549,560
+208% +$7.22M
WIX icon
28
WIX.com
WIX
$2.7B
$10.7M 0.99%
154,065
-39,739
-21% -$2.97M
MB
29
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
$10.7M 0.99%
394,245
-60,450
-13% -$1.66M
AXON
30
Axon Enterprise
AXON
$49.1B
$10.4M 0.96%
414,566
-17,645
-4% -$432K
SPNC
31
DELISTED
Spectranetics Corp
SPNC
$9.39M 0.87%
244,644
+82,836
+51% +$2.39M
CSII
32
DELISTED
Cardiovascular Systems, Inc.
CSII
$9.24M 0.85%
286,660
-74,435
-21% -$2.27M
PLOW icon
33
Douglas Dynamics
PLOW
$1.06B
$9.22M 0.85%
280,211
-33,688
-11% -$1.04M
NEO icon
34
NeoGenomics
NEO
$2.02B
$9.06M 0.84%
1,011,124
-296,755
-23% -$2.36M
NKTR icon
35
Nektar Therapeutics
NKTR
$2.47B
$8.98M 0.83%
30,613
-6,885
-18% -$1.99M
ALKS icon
36
Alkermes
ALKS
$8.32B
$8.93M 0.82%
154,005
+1,281
+0.8% +$74.4K
BIO icon
37
Bio-Rad Laboratories Class A
BIO
$9.31B
$8.84M 0.81%
39,055
+21,091
+117% +$4.6M
EVH icon
38
Evolent Health
EVH
$346M
$8.16M 0.75%
321,888
-33,571
-9% -$807K
HUBS icon
39
HubSpot
HUBS
$12.8B
$8.11M 0.75%
123,380
+69,110
+127% +$4.67M
PAYC icon
40
Paycom
PAYC
$8.15B
$8.1M 0.75%
118,396
+13,850
+13% +$891K
KAMN
41
DELISTED
Kaman Corp
KAMN
$7.98M 0.74%
160,041
-54,492
-25% -$2.65M
OXFD
42
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$7.82M 0.72%
465,120
+169,643
+57% +$2.54M
TNC icon
43
Tennant Co
TNC
$1.49B
$7.71M 0.71%
104,469
-56,679
-35% -$4.11M
RBC icon
44
RBC Bearings
RBC
$18.1B
$7.65M 0.71%
75,183
-24,631
-25% -$2.46M
RUSHA icon
45
Rush Enterprises Class A
RUSHA
$6.36B
$7.55M 0.7%
456,696
-205,240
-31% -$3.29M
INST
46
DELISTED
Instructure, Inc.
INST
$7.53M 0.69%
255,383
+42,666
+20% +$1.09M
SHOP icon
47
Shopify
SHOP
$187B
$7.26M 0.67%
835,240
-1,290,830
-61% -$10.9M
NXST icon
48
Nexstar Media Group
NXST
$5.8B
$7.11M 0.66%
118,963
+61,488
+107% +$3.85M
TRVG
49
trivago
TRVG
$366M
$7.08M 0.65%
59,888
-31,765
-35% -$2.79M
PPBI
50
DELISTED
Pacific Premier Bancorp
PPBI
$7.02M 0.65%
190,216
+118,978
+167% +$4.28M

Similar funds

Granahan Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Granahan Investment Management held 246 positions worth $1.08B, up 8.9% from $996M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Granahan Investment Management's Q2 2017 filing shows 35 new, 107 increased, 81 reduced and 17 closed positions. Its largest new stake was Strategic Education: 190,000 shares worth $17.7M. The largest sale was Affiliated Managers Group, an estimated $12.4M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.

  • Granahan Investment Management's largest Q2 2017 buy was Strategic Education: 190,000 shares worth $17.7M.
  • Granahan Investment Management added most to 2U Inc in Q2 2017, an estimated $8.12M increase.
  • Granahan Investment Management's biggest Q2 2017 reduction was Affiliated Managers Group, cutting an estimated $12.4M.
  • Granahan Investment Management fully exited ZELTIQ Aesthetics, Inc. in Q2 2017, selling an estimated $8.78M.
  • Granahan Investment Management's ten largest holdings make up 23% of its $1.08B portfolio in Q2 2017.
  • Granahan Investment Management opened 35 new positions and closed 17 in Q2 2017.
  • Granahan Investment Management's portfolio value rose 8.9% quarter-over-quarter to $1.08B.

Based on Granahan Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.